Analysis of Differentiated Approach Effectiveness in Patients with Varying Degrees of Severity of Chronic Ocular Ischemic Syndrome Caused by Internal Carotid Artery Stenosis

Purpose: to study the effect of differentiated treatment approach in patients with varying degrees of severity chronic ocular ischemic syndrome (OIS) on clinical course of disease and hemodynamics of eyes in prospective research.

Patients and methods. The research included 20 patients with chronic OIS. Patients were divided into 4 groups due to severity of chronic OIS and type of treatment. 1st group — 7 patients with moderate severity chronic OIS and hemodynamically significant of internal carotid artery stenosis (ICAS); only carotid endarterectomy (CE) of ICAS was performed. 2nd group — 6 patients with severe degree chronic OIS and hemodynamically significant stenosis of ICAS; 2 weeks before CE, panretinal photocoagulation (PRP) of retinal capillary non-perfusion areas was performed. 3rd group — 4 patients with severe degree chronic OIS, complicated by rubeosis iris and increased IOP on hypotensive regimen, on the background of hemodynamically insignificant ICAS; PRP of retina was performed. 4th group — 3 patients with moderate severity chronic OIS with hemodynamically insignificant ICAS; course of neuroprotective therapy was performed. All patients underwent standard and specialized ophthalmologic examination methods. Assessment of blood flow in brachiocephalic vessels, eye vessels was performed by ultrasound scan, spiral computed tomography, OCT-angiography with the AngioVue.

Results. Monitoring of patients’ groups for 1 year after chronic OIS treatment allowed us to determine tactics of patient management depending on degree of ICAS and severity of chronic OIS. Reconstructive surgery at hemodynamically significant ICAS caused positive dynamic in intraocular blood flow, which contributed to improvement and preservation of BCVA in 71 % of patients. Preventive PRP of retina, before performing reconstructive surgery of ICAS, optimized and reduced the time of visual recovery. PRP of retina as independent method of treatment of chronic OIS, complicated by neovascular glaucoma, caused full or partial regression of neovascularization in iris, which increased possibilities of its effective treatment. Neuroprotective pharmacotherapy in early stages of chronic OIS, in absence of indications for reconstructive surgery and PRP of retina, improved the prognosis for patients’ vision.

Conclusion. Differentiated treatment approach in patients with chronic OIS, due to changes of hemodynamics of internal carotid artery, has improved indexes of hemodynamic and visual acuity.

1. Zavgorodnyaya T.S., Sarzhevskaya L.E., Bezdenezhnaya O.A., Bezugla E.A. Ocular ischemic syndrome. Modern principles of diagnosis and treatment. Zaporozhie, 2012. 248 p. (In Russ.).

2. Tarasova L.N. Ocular ischemic syndrome. Moscow: Medicine, 2003. 176 p. (In Russ.).

3. Pokrovskii A.V., Beloyartsev D.F., Adyrkhaev Z.A., Timina I.E., Losik I.A. Remote results of reconstructive operations in pathological deformity of the internal carotid artery. Angiology and Vascular Surgery = Angiologiya i sosudistaya khirurgiya. 2012;18(1):92–104 (In Russ.).

4. Frolov M.A., Alkam K.M. The manifestation of ocular ischemic syndrome in patients with atherosclerotic stenosis of the extracranial parts of carotid arteries. Bulletin of the N.I. Pirogov National Medical-Surgical Center = Vestnik Natsional’nogo mediko-khirurgicheskogo tsentra im. N.I. Pirogova. 2013;8(4):25–28 (In Russ.).

5. Makkayeva S.M., Puzin M.N., Ramazanova L.Sh. The therapy of ocular ischemic syndrome at the background of cerebrovascular pathology. Practical Neurology and Neurorehabilitation = Prakticheskaya nevrologiya i neyroreabilitatsiya. 2009;(3):41–43 (In Russ.).

6. Klag M.J., Whelton P.K., Seidler A.J. Decline in US stroke mortality: demographic trends and antihypertensive treatment. Stroke. 1989;20(1):14–21. DOI: 10.1161/01. str.20.1.14

7. Chen C.S., Miller N.R. Ocular ischemic syndrome: review of clinical presentations, etiology, investigation, and management. Compr Ophthalmol Update. 2007;8(1):17–28.

8. Terelak-Borys B., Skonieczna K., Grabska-Liberek I. Ocular ischemic syndrome — a systematic review. Med Sci Monit. 2012;18(8):138–144. DOI: 10.12659/msm.883260

9. Borisova L.I., Cherednichenko L.P., Karpov S.М. Ophthalmologic manifestations of osteochondrosis of the cervical spine depending on the stage of the pathological process. Fundamental Research = Fundamental’nye issledovaniya. 2014;(4-1):40–43 (In Russ.).

10. Kiseleva T.N., Tarasova L.N., Fokin A.A. The value of reconstructive operations on the carotid arteries for the correction of ocular ischemic syndrome. Angiology and Vascular Surgery = Angiologiya i sosudistaya khirurgiya. 2001;7(3):15–21 (In Russ.).

11. Yartseva N.S., Deev L.A., Gavrilova N.A. Selected lectures of ophthalmology. Vol. 3. Moscow, 2008. 252 p. (In Russ.).

12. Malhotra R., Gregory-Evans K. Management of ocular ischaemic syndrome. Br J Ophthalmol. 2000;84(12):1428–1431. DOI: 10.1136/bjo.84.12.1428

13. Mendrinos E., Machinie T.G., Pournaras C.J. Ocular ischemic syndrome. Surv Ophthalmol. 2010;55(1):2–34. DOI: 10.1016/j.survophthal.2009.02.024

14. Bondar V.Yu., Maslov M.G., Netbay N.N., Breev D.V., Sedunov A.V., Khairov R.R., Udinkan A.G., Krikun T.A., Polyakov K.V. Features of the clinical course of the hospital period after carotid stenting and carotid endarterectomy. Angiology and Vascular Surgery = Аngiologiya i sosudistaya khirurgiya. 2014;20(2):52–56 (In Russ.).

15. Gavrilenko A.V., Kuklin A.V., Abramyan A.V., Kiseleva T.N. Results of carotid endarterectomy in patients with ocular ischemic syndrome caused by stenosis of carotid arteries. Annals of Surgery = Аnnaly khirurgii. 2014;(1):30–37 (In Russ.).

16. Kayotkina E.V., Chistyakova S.V., Kuvyrkova O.I. Results of complex treatment of ocular ischemic syndrome. Annals of Orenburg State University = Vestnik Orenburgskogo gosudarstvennogo universiteta. 2015;(12):100–103 (In Russ.).

17. Sivalingam A., Brown G.C., Magargal L.E. The ocular ischemic syndrome. III. Visual prognosis and the effect of treatment. International Ophthalmology. 1991;15(1):15– 20. DOI: 10.1007/bf00150974

18. Shah P.J., Ellis B., DiGiovine L.R., Hogg J.P., Leys M.J. Central retinal artery occlusion following laser treatment for ocular ischemic aortic arch syndrome. GMS Ophthalmol Cases. 2015;(5). DOI: 10.3205/oc000036

19. Sowka J.W., Gurwood A.S., Kabat A.G. The handbook of ocular disease management. Review of optometry. 2009;(11):40–42.

20. Tuzlaev V.V., Kravchenko I.Z., Egorov V.V., Smolyakova G.P. Favorable outcome of chronic ischemic retinopathy with use of combined treatment (clinical case). Modern Technologies in Ophthalmology = Sovremennyye tekhnologii v oftal’mologii. 2018;(2):131–133 (In Russ.).

21. Bachinskaya N.Yu., Pokrovenko I.V., Demchenko E.V., Kopchak O.O., Kholin V.A. Effect of Gliatilin on the neuropsychological and neurophysiological parameters for mild cognitive impairment syndrome in elderly patients with dyscirculatory encephalopathy. Ukrainian Neurological Journal = Ukrainskiy nevrologicheskiy zhurnal. 2013;(4):94– 102 (In Russ.).

22. Krylova N.G., Belskaya G.N. Actovegin in treatment of patients with chronic cerebral ischemia. Neurology and Neurosurgery in Belarus = Nevrologiya i neyrokhirurgiya v Belarusi. 2009;(2):66–70 (In Russ.).